NCT01920841

Brief Summary

The purpose of this study is to evaluate efficacy of two lipolytic creams differing in their bases and demonstrate that their herbal ingredients can reduce the size of the thigh and smooth the appearance of the thigh skin. It is hypothesized that creams with two different cream bases containing herbal products that stimulate the lipolytic process through stimulation of the beta-adrenergic receptor, with one cream base applied to each thigh daily 5 days a week for 4 weeks will reduce thigh girth and smooth the thigh skin compared to baseline.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 12, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

December 18, 2015

Status Verified

December 1, 2015

Enrollment Period

9 months

First QC Date

August 8, 2013

Last Update Submit

December 17, 2015

Conditions

Keywords

lipolyticherbal extractsthigh girththigh smoothness

Outcome Measures

Primary Outcomes (1)

  • Difference in girth of the two thighs from baseline over the course of the treatment period

    Creams with two different cream bases containing forskolin, nerium oleander, salicin,caffeine, and green tea extract that have been shown to be safe topically will be evaluated. Both cream bases will be applied to the thighs daily 5 days a week for 4 weeks, with each thigh receiving the same cream base everyday. The thighs will be measured weekly

    Four weeks

Secondary Outcomes (2)

  • Smoothness of the skin on the thighs treated with the two lipolytic creams differing in their bases compared to baseline using standardized photographs at baseline and at the end of the treatment.

    Four weeks

  • Adverse events

    4 weeks

Study Arms (2)

Left (A), Right (B)

EXPERIMENTAL

Cream A applied to left thigh and Cream B to right thigh

Other: Cream A applied to left thigh and Cream B to right thigh

Left (B) Right (A)

EXPERIMENTAL

Cream B applied to left thigh and Cream A to right thigh

Other: Cream B applied to left thigh and Cream A to right thigh

Interventions

Half the participants will receive Cream A applied to the left thigh, and Cream B applied to the right thigh

Left (A), Right (B)

Half the participants will receive Cream B applied to the left thigh and Cream A applied to the right thigh

Left (B) Right (A)

Eligibility Criteria

Age18 Years - 52 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women who feel that their thighs are too large and the skin is insufficiently smooth.

You may not qualify if:

  • Pregnant or nursing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

Location

MeSH Terms

Conditions

Weight Loss

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Frank L Greenway, M.D.

    Pennington Biomedical Research Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 8, 2013

First Posted

August 12, 2013

Study Start

June 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

December 18, 2015

Record last verified: 2015-12

Locations